Organigram Changes Up Executive Staff After Product Recall

Image: The Canadian Press

Following a product recall in December of last year when traces of unauthorized ingredients were found in cannabis lots, Organigram is changing up their executive staff, appointing Greg Engel as CEO and Denis Arsenault as executive chairman as part of the board of directors.

Due to the presence of ingredients myclobutanil and bifenazate, which are not found in the thirteen pesticides that are authorized for use on cannabis plants under the Pest Control Products Act, the company initiated a voluntary Type III recall and then a voluntary Type II recall.

As reported by the Globe and Mail, the banned pesticide found in Organigram’s cannabis lots produces hydrogen cyanide when heated and can cause serious health problems in those who consume it.

In another news release, Organigram delivered its findings from the investigation triggered by the traces of pesticides found. The company said that the inquiry was thorough and was undertaken with the full cooperation and assistance of Health Canada and that no hard evidence leading to the contamination was discovered.

Greg Engel will take on his new role effective March 13, taking over for Organigram’s current CEO Denis Arsenault. Engel will also join the company’s board of directors, replacing Larry Rogers.

In a new release, Arsenault explained that the decision to turn day-to-day management over to an executive of Engel’s calibre has been planned for some time.

“It has been three years to the day since I joined Organigram and I’ve achieved most of my goals as company CEO and believe it’s time for me to pass the torch to a seasoned executive with demonstrated leadership skills,” he said.

“I will stay active in the areas of investor relations and capital markets and look forward to working with Greg as he leads us through our next phase of expansion.”